Skip to main content
ILMN logo
ILMN
(NASDAQ)
Illumina, Inc.
$127.38-- (--)
Loading... - Market loading

Illumina (ILMN) Stock Price & Financial Analysis

Illumina Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$124.00 - $130.00
52-Week High$155.53
52-Week Low$68.70
Open$124.44
Volume960.39K
Average Volume (3M)960.39K
Market Cap19.62B
Shares Outstanding154.00M
P/E Ratio (TTM)22.94
Price to Sales (P/S)4.49
Price to Book (P/B)7.16
EV/EBITDA13.79
Revenue (TTM)4.34B
Net Income (TTM)850.00M
Free Cash Flow (TTM)931.00M
EPS (TTM)$5.52
Profit Margin19.57%
Operating Margin18.79%
Return on Equity (ROE)31.22%
Debt to Equity0.73
50-Day MA$128.11
200-Day MA$114.58
52-Week Change61.54%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Illumina

What is the current stock price for ILMN?

As of the latest trading session, ILMN stock trades at $127.38. The 52-week range is $68.70–$155.53, with a day range of $124.00–$130.00.

What is the P/E ratio for ILMN?

Illumina's trailing P/E ratio is 22.9, meaning investors pay $22.9 for every $1 of annual earnings. Illumina operates in the Healthcare sector.

Does ILMN pay dividends?

Illumina does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ILMN?

Based on 6 analysts, the consensus for ILMN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ILMN?

Illumina's market capitalization is $19.62B, classifying it as a large-cap company. Illumina operates in the Healthcare sector within the Diagnostics & Research industry.